- Teva Pharmaceutical Industries Ltd ADR (TEVA): 11.43%
- Bank Leumi Le-Israel BM (LUMI.TA): 9.26%
- Bank Hapoalim BM (POLI.TA): 8.13%
- Elbit Systems Ltd (ESLT.TA): 6.50%
- Check Point Software Technologies Ltd (CHKP): 3.64%
- Israel Discount Bank Ltd Class A (DSCT.TA): 3.63%
- Mizrahi Tefahot Bank Ltd (MZTF.TA): 3.24%
- Phoenix Financial Ltd (PHOE.TA): 3.18%
- Tower Semiconductor Ltd (TSEM.TA): 2.69%
- Nova Ltd (NVMI): 2.26%
VanEck Israel ETF (ISRA) ETF Analysis
VanEck Israel ETF (ISRA) offers investors exposure to Israeli equities, seeking to replicate the BlueStar Israel Global Index. With an AUM of $0.14 billion, ISRA provides a focused approach to investing in Israeli companies. The ETF's expense ratio is 0.71%.
ISRA's top holdings include Teva Pharmaceutical Industries Ltd ADR and major Israeli banks, making it a targeted play on the Israeli economy.
VanEck Israel ETF (ISRA) ETF — Price, Holdings & Analysis
VanEck Israel ETF (ISRA) offers investors exposure to Israeli equities, seeking to replicate the BlueStar Israel Global Index. With an AUM of $0.14 billion, ISRA provides a focused approach to investing in Israeli companies. The ETF's expense ratio is 0.71%. ISRA's top holdings include Teva Pharmaceutical Industries Ltd ADR and major Israeli banks, making it a targeted play on the Israeli economy.
ETF 개요
VanEck Israel ETF (ISRATM) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the BlueStar Israel Global Index (BLSNTR), which is comprised of equity securities, which may include depositary receipts, of publicly traded companies that are generally considered by the Index Provider to be Israeli companies.
VanEck Israel ETF (ISRA) aims to mirror the performance of the BlueStar Israel Global Index, providing a concentrated investment in Israeli companies. ISRA's portfolio consists of 81개 보유 종목, offering exposure to various sectors within the Israeli economy. The fund is particularly weighted towards Financial Services, which constitutes 38.5% of the portfolio, followed by Technology at 21.7% and Healthcare at 12.2%. Top holdings include Teva Pharmaceutical Industries Ltd ADR (11.43%), Bank Leumi Le-Israel BM (9.26%), and Bank Hapoalim BM (8.13%). This ETF is designed for investors seeking targeted exposure to the Israeli equity market, offering a way to participate in the growth of Israeli businesses. With over 91% of its holdings based in Israel, ISRA provides a direct investment in the country's economy.
위험 지표
ISRA carries a concentration risk due to its focus on a single country, Israel, which accounts for over 91% of its holdings. The fund's sector allocation also presents a risk, with a significant portion of the portfolio concentrated in Financial Services (38.5%) and Technology (21.7%). A downturn in either of these sectors could significantly impact the ETF's performance. The expense ratio of 0.71% is higher than some broad-market equity ETFs, creating a drag on returns, especially in periods of underperformance. ISRA's beta of 1.18 indicates that it is more volatile than the broader market. these may be worth researching factors when evaluating ISRA for their portfolios.
운용보수율
0.71%
주요 보유 종목
펀드는 어떻게 배분되어 있나요?
- 금융 서비스: 38.5%
- 기술: 21.7%
- 헬스케어: 12.2%
- 산업재: 10.8%
- 부동산: 4.7%
- 유틸리티: 4.5%
- 경기소비재: 2.0%
- 에너지: 2.0%
- 커뮤니케이션 서비스: 1.9%
- 필수소비재: 1.6%
- 기초 소재: 0.2%
- 이스라엘: 91.1%
- 미국: 7.9%
- 영국: 0.4%
- 싱가포르: 0.3%
- Jersey: 0.2%
- 기타: 0.1%
배당수익률
0.00%
- State Street Technology Select Sector SPDR ETF (XLK) — 비용 비율 0.08%
- State Street Financial Select Sector SPDR ETF (XLF) — 비용 비율 0.08%
- State Street Energy Select Sector SPDR ETF (XLE) — 비용 비율 0.08%
- iShares Russell 2000 ETF (IWM) — 비용 비율 0.19%
- iShares MSCI EAFE ETF (EFA) — 비용 비율 0.32%
- iShares MSCI Emerging Markets ETF (EEM) — 비용 비율 0.72%
- Invesco QQQ Trust, Series 1 (QQQ) — 비용 비율 0.18%
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 비용 비율 0.16%
- VanEck Junior Gold Miners ETF (GDXJ) (주식) — 비용 비율 0.51%
- VanEck Uranium and Nuclear ETF (NLR) (주식) — 비용 비율 0.56%
- VanEck Gold Miners ETF (GDX) (주식) — 비용 비율 0.51%
- VanEck Emerging Markets High Yield Bond ETF (HYEM) (멀티에셋 ETF) — 비용 비율 0.40%
- VanEck Green Infrastructure ETF (RNEW) (주식) — 비용 비율 0.47%
- VanEck Technology TruSector ETF (TRUT) (주식) — 비용 비율 0.14%
위험 지표
- 베타: 1.18
질문 및 답변
What is ISRA and what does it track?
VanEck Israel ETF (ISRA) seeks to replicate the price and yield performance of the BlueStar Israel Global Index. This index is composed of equity securities of publicly traded companies that are generally considered to be Israeli companies. ISRA provides investors with a focused approach to investing in the Israeli equity market, offering exposure to a range of sectors within the Israeli economy. As of 2026-03-15, ISRA has an AUM of $0.14 billion and holds 81 different stocks.
What is the expense ratio for ISRA?
The expense ratio for the VanEck Israel ETF (ISRA) is 0.71%. This means that for every $10,000 invested in the fund, $71 is used to cover the fund's operating expenses. While this provides access to a specific market, it is important to consider the cost relative to potential returns. The expense ratio can impact the overall profitability of the investment, especially when compared to broader market ETFs with lower expense ratios.
What are the top holdings in ISRA?
As of 2026-03-15, the top holdings in the VanEck Israel ETF (ISRA) are: Teva Pharmaceutical Industries Ltd ADR, with a weight of 11.43%; Bank Leumi Le-Israel BM, at 9.26%; Bank Hapoalim BM, comprising 8.13%; Elbit Systems Ltd at 6.50%; and Check Point Software Technologies Ltd, making up 3.64% of the fund. These top holdings represent a significant portion of the ETF's portfolio, reflecting the fund's concentration in key Israeli companies. Investors should be aware of the performance of these companies, as they can significantly impact ISRA's overall returns.
Is ISRA a good long-term investment?
Whether ISRA is a suitable long-term investment depends on an individual's investment goals, risk tolerance, and outlook on the Israeli economy. ISRA provides targeted exposure to Israeli equities, which can offer diversification benefits. However, it also carries concentration risk due to its focus on a single country. As of 2026-03-15, ISRA has a beta of 1.18, indicating higher volatility than the market. Past performance does not guarantee future results, and investors should carefully consider these factors before investing.
How does ISRA compare to similar ETFs?
ISRA stands out with its specific focus on Israeli equities. While other regional or global ETFs may include some Israeli companies, ISRA offers a more concentrated exposure. With an expense ratio of 0.71% and AUM of $0.14 billion, ISRA's expense ratio may be higher than broader market ETFs. Investors seeking pure-play exposure to the Israeli market may find ISRA a suitable option, while those looking for broader diversification may prefer other ETFs.
Does ISRA pay dividends?
As of 2026-03-15, the VanEck Israel ETF (ISRA) has a dividend yield of 0.00%. This indicates that the fund is not currently distributing dividends to its shareholders. Investors seeking income-generating investments may need to consider other ETFs with a history of dividend payments. The lack of a dividend yield may be a factor for investors prioritizing current income over capital appreciation.